Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 721

1.

Hyperuricemia and Progression of CKD in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort Study.

Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ.

Am J Kidney Dis. 2015 Dec;66(6):984-92. doi: 10.1053/j.ajkd.2015.06.015. Epub 2015 Jul 21.

2.

Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.

Warady BA, Abraham AG, Schwartz GJ, Wong CS, Muñoz A, Betoko A, Mitsnefes M, Kaskel F, Greenbaum LA, Mak RH, Flynn J, Moxey-Mims MM, Furth S.

Am J Kidney Dis. 2015 Jun;65(6):878-88. doi: 10.1053/j.ajkd.2015.01.008. Epub 2015 Mar 19.

3.

Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.

Ng DK, Schwartz GJ, Warady BA, Furth SL, Muñoz A.

Am J Kidney Dis. 2017 Sep;70(3):397-405. doi: 10.1053/j.ajkd.2017.03.019. Epub 2017 May 24.

4.

Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.

Lebensburger JD, Cutter GR, Howard TH, Muntner P, Feig DI.

Pediatr Nephrol. 2017 Sep;32(9):1565-1573. doi: 10.1007/s00467-017-3658-8. Epub 2017 Apr 5.

5.

Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease.

Nacak H, van Diepen M, Qureshi AR, Carrero JJ, Stijnen T, Dekker FW, Evans M.

Nephrol Dial Transplant. 2015 Dec;30(12):2039-45. doi: 10.1093/ndt/gfv225. Epub 2015 Jul 16.

6.

Uric acid: association with rate of renal function decline and time until start of dialysis in incident pre-dialysis patients.

Nacak H, van Diepen M, de Goeij MC, Rotmans JI, Dekker FW; PREPARE-2 study group.

BMC Nephrol. 2014 Jun 16;15:91. doi: 10.1186/1471-2369-15-91.

7.

Joint association of hyperuricemia and reduced GFR on cardiovascular morbidity: a historical cohort study based on laboratory and claims data from a national insurance provider.

Neri L, Rocca Rey LA, Lentine KL, Hinyard LJ, Pinsky B, Xiao H, Dukes J, Schnitzler MA.

Am J Kidney Dis. 2011 Sep;58(3):398-408. doi: 10.1053/j.ajkd.2011.04.025. Epub 2011 Jul 23.

PMID:
21783292
8.

Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.

Chen SC, Chang JM, Yeh SM, Su HM, Chen HC.

Am J Hypertens. 2013 Feb;26(2):243-9. doi: 10.1093/ajh/hps020. Epub 2012 Dec 28.

PMID:
23382409
9.

Impact of Uric Acid Levels on Kidney Disease Progression.

Rincon-Choles H, Jolly SE, Arrigain S, Konig V, Schold JD, Nakhoul G, Navaneethan SD, Nally JV Jr, Rothberg MB.

Am J Nephrol. 2017;46(4):315-322. doi: 10.1159/000481460. Epub 2017 Oct 13.

PMID:
29032376
10.

Serum uric acid level as an indicator for CKD regression and progression in patients with type 2 diabetes mellitus-a 4.6-year cohort study.

Chang YH, Lei CC, Lin KC, Chang DM, Hsieh CH, Lee YJ.

Diabetes Metab Res Rev. 2016 Sep;32(6):557-64. doi: 10.1002/dmrr.2768. Epub 2015 Dec 22.

PMID:
26590369
11.

Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia.

Levy GD, Rashid N, Niu F, Cheetham TC.

J Rheumatol. 2014 May;41(5):955-62. doi: 10.3899/jrheum.131159. Epub 2014 Apr 1.

PMID:
24692523
12.

Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.

Fathallah-Shaykh SA, Flynn JT, Pierce CB, Abraham AG, Blydt-Hansen TD, Massengill SF, Moxey-Mims MM, Warady BA, Furth SL, Wong CS.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):571-7. doi: 10.2215/CJN.07480714. Epub 2015 Jan 29.

13.

Uric acid and incident chronic kidney disease in a large health check-up population in Taiwan.

Wang S, Shu Z, Tao Q, Yu C, Zhan S, Li L.

Nephrology (Carlton). 2011 Nov;16(8):767-76. doi: 10.1111/j.1440-1797.2011.01513.x.

PMID:
21854506
14.

Uric acid and long-term outcomes in CKD.

Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V.

Am J Kidney Dis. 2009 May;53(5):796-803. doi: 10.1053/j.ajkd.2008.12.021. Epub 2009 Mar 20.

15.

Association of income level with kidney disease severity and progression among children and adolescents with CKD: a report from the Chronic Kidney Disease in Children (CKiD) Study.

Hidalgo G, Ng DK, Moxey-Mims M, Minnick ML, Blydt-Hansen T, Warady BA, Furth SL.

Am J Kidney Dis. 2013 Dec;62(6):1087-94. doi: 10.1053/j.ajkd.2013.06.013. Epub 2013 Aug 7.

16.

Uric acid levels, kidney function, and cardiovascular mortality in US adults: National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 1999-2002.

Odden MC, Amadu AR, Smit E, Lo L, Peralta CA.

Am J Kidney Dis. 2014 Oct;64(4):550-7. doi: 10.1053/j.ajkd.2014.04.024. Epub 2014 Jun 4.

17.

Effect of Urate Lowering Therapy on Renal Disease Progression in Hyperuricemic Patients with Chronic Kidney Disease.

Kim Y, Shin S, Kim K, Choi S, Lee K.

J Rheumatol. 2015 Nov;42(11):2143-8. doi: 10.3899/jrheum.150067. Epub 2015 Oct 1.

PMID:
26428209
18.

Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.

Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989-1998. Epub 2016 Aug 25.

19.

J-shaped mortality relationship for uric acid in CKD.

Suliman ME, Johnson RJ, García-López E, Qureshi AR, Molinaei H, Carrero JJ, Heimbürger O, Bárány P, Axelsson J, Lindholm B, Stenvinkel P.

Am J Kidney Dis. 2006 Nov;48(5):761-71.

PMID:
17059995
20.

Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function.

Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E.

Diabetes Care. 2012 Jan;35(1):99-104. doi: 10.2337/dc11-1346. Epub 2011 Oct 25.

Supplemental Content

Support Center